Sept 2019 Quarterly Shareholder Update and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Successful Major Milestone - Human Retina in a Dish Models
- Strategic Partnership and Lead Program
- Successful Time-Course Studies in Animals
- Successful Competitive Drug Evaluation in Animals
- Response to ASX Aware Query
Later from PYC Therapeutics
- $26.8m Fully Underwritten Accelerated Entitlement Offer
- Entitlement Offer - Investor Presentation
- PYCs Institutional Entitlement Offer Closes
- Retail Offer Document
- Conclusion of Genentech Antimicrobial Collaboration
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics